Prague Med. Rep. 2020, 121, 194-199
https://doi.org/10.14712/23362936.2020.18
Type-I Cryoglobulinaemia Associated to Monoclonal Gammapathy of Undetermined Significance
References
1. 2015) Diagnostic and therapeutic options for peripheral vasculitic neuropathy. Ther. Adv. Musculoskelet. Dis. 7, 45–55.
< , F. (https://doi.org/10.1177/1759720X14566617>
2. 2015) Cryoglobulinemia vasculitis. Am. J. Med. 128, 950–955.
< , P., Comarmond, C., Domont, F., Savey, L., Saadoun, D. (https://doi.org/10.1016/j.amjmed.2015.02.017>
3. 2014) Diagnostics and treatment of cryoglobulinaemia: It takes two to tango. Clin. Rev. Allergy Immunol. 47, 299–310.
< , J., Cohen Tervaert, J. W. (https://doi.org/10.1007/s12016-013-8390-y>
4. 2011) Crioglobulinemia tipo I de desenlace fatal. Actas Dermatosifilogr. 102, 212–215.
< , B., Vitiello, M., Abuchar, A., Kerdel, F. A. (https://doi.org/10.1016/j.ad.2010.10.011>
5. 2017) A prospective, observational study of patients with uncommon distal symmetric painful small-fiber neuropathy. PLoS One 12, e0183948.
< , J. L., Liao, M. F., Hsu, H. C., Weng, Y. C., Lo, A. L., Chang, K. H., Chang, H. S., Kuo, H. C., Huang, C. C., Ro, L. S. (https://doi.org/10.1371/journal.pone.0183948>
6. 2005) A case of type-I cryoglobulinemia associated with a monoclonal gammapathy of undetermined significance (MGUS). J. Dermatol. 32, 128–131.
< , M., Takahashi, H. (https://doi.org/10.1111/j.1346-8138.2005.tb00730.x>
7. 2018) Cryoglobulins: An update on detection, mechanisms and clinical contribution. Autoimmun. Rev. 17, 457–464.
< , M. N., Miossec, P. (https://doi.org/10.1016/j.autrev.2017.11.035>
8. 2015) Anticuerpos IgM anti-glicoproteína asociada a mielina en pacientes con polineuropatía y gammapatía monoclonal de significado incierto. Bioquim. Patol. Clin. 79, 10–19.
, S. G., Carballo, O. G., Lessa, C. F. (
9. 2017) Crioglobulinas: Detección, cuantificación, tipificación inmunoquímica y expresión clínica. Bioquim. Patol. Clin. 81, 27–34.
, S. G., Ingénito, F., Lessa, C., Carballo, O. G. (
10. 2012) The cryoglobulinaemias. Lancet 379, 348–360.
< , M., Stone, J. H., Cid, M. C., Bosch, X. (https://doi.org/10.1016/S0140-6736(11)60242-0>
11. 2017) Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia. Am. J. Hematol. 92, 668–673.
< , S., Rajkumar, S. V., Dispenzieri, A., Lacy, M. Q., Gertz, M. A., Buadi, F. K., Hayman, S. R., Dingli, D., Kapoor, P., Gonsalves, W. I., Go, R. S., Hwa, Y. L., Leung, N., Fonder, A. L., Hobbs, M. A., Zeldenrust, S. R., Russell, S. J., Lust, J. A., Kyle, R. A., Kumar, S. K. (https://doi.org/10.1002/ajh.24745>
12. 2015) IgM MGUS associated with anti-MAG neuropathy: a single institution experience. Ann. Hematol. 94, 1011–1016.
< , G., Mir, T. A., Pandey, M. K., Sivik, J. K., Raheda, D. (https://doi.org/10.1007/s00277-014-2294-7>
13. 1992) Vasculitic neuropathy in a patient with cryoglobulinemia and anti-MAG IgM monoclonal gammapathy. Muscle Nerve 15, 891–898.
< , F. P., Lovelace, R. E., Ding, X. S., Sadip, S. A., Petty, G. W., Sherman, W. H. (https://doi.org/10.1002/mus.880150805>